196 related articles for article (PubMed ID: 30516775)
1. A gold(i) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs.
Schmidt C; Albrecht L; Balasupramaniam S; Misgeld R; Karge B; Brönstrup M; Prokop A; Baumann K; Reichl S; Ott I
Metallomics; 2019 Mar; 11(3):533-545. PubMed ID: 30516775
[TBL] [Abstract][Full Text] [Related]
2. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
3. Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase.
Büssing R; Karge B; Lippmann P; Jones PG; Brönstrup M; Ott I
ChemMedChem; 2021 Nov; 16(22):3402-3409. PubMed ID: 34268875
[TBL] [Abstract][Full Text] [Related]
4. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
6. Chemistry, structure, and biological roles of Au-NHC complexes as TrxR inhibitors.
Karaaslan MG; Aktaş A; Gürses C; Gök Y; Ateş B
Bioorg Chem; 2020 Jan; 95():103552. PubMed ID: 31911299
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.
Rubbiani R; Salassa L; de Almeida A; Casini A; Ott I
ChemMedChem; 2014 Jun; 9(6):1205-10. PubMed ID: 24677779
[TBL] [Abstract][Full Text] [Related]
8. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
11. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
12. Novel triazolium based 11(th) group NHCs: synthesis, characterization and cellular response mechanisms.
Pellei M; Gandin V; Marinelli M; Orsetti A; Del Bello F; Santini C; Marzano C
Dalton Trans; 2015 Dec; 44(48):21041-52. PubMed ID: 26587827
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligands.
Boselli L; Ader I; Carraz M; Hemmert C; Cuvillier O; Gornitzka H
Eur J Med Chem; 2014 Oct; 85():87-94. PubMed ID: 25078312
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Ag(I) and Au(I) NHC-carbenes bind DNA and show TrxR inhibition.
Guarra F; Busto N; Guerri A; Marchetti L; Marzo T; García B; Biver T; Gabbiani C
J Inorg Biochem; 2020 Apr; 205():110998. PubMed ID: 31981769
[TBL] [Abstract][Full Text] [Related]
18. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
19. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium.
Zou T; Lok CN; Wan PK; Zhang ZF; Fung SK; Che CM
Curr Opin Chem Biol; 2018 Apr; 43():30-36. PubMed ID: 29136524
[TBL] [Abstract][Full Text] [Related]
20. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
